Markets:

Overview

News

Currencies

International

Treasuries

Virios Therapeutics, Inc. - Common Stock (NQ:VIRI)

0.1550 UNCHANGED

Last Price Updated: 4:00 PM EDT, Oct 8, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Virios Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Virios' Promising Fibromyalgia Treatment Candidate Expects September 2022 Phase 2b Results

July 19, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

July 15, 2022

Via Benzinga

Virios Therapeutics’ Study Featured in Peer-Reviewed Journal Publication Highlighting Association of Herpes Simplex Type 1 Viral Infection with Common Gastrointestinal Disorders, Including in Patients with Comorbid Fibromyalgia

June 01, 2022

From Virios Therapeutics, Inc.

Via Business Wire

Virios Therapeutics: Q1 Earnings Insights ↗

May 12, 2022

Virios Therapeutics (NASDAQ:VIRI) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Scheduled For November 11, 2021 ↗

November 11, 2021

Companies Reporting Before The Bell • NICE (NASDAQ:NICE) is likely to report quarterly earnings at $1.58 per share on revenue of $465.75 million. • Reshape...

Via Benzinga

Virios Therapeutics Announces First Quarter 2022 Financial Results and Provides Corporate Update

May 12, 2022

From Virios Therapeutics, Inc.

Via Business Wire

Preview: Virios Therapeutics's Earnings ↗

May 11, 2022

Virios Therapeutics (NASDAQ:VIRI) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Virios...

Via Benzinga

Virios Therapeutics to Report First Quarter 2022 Financial Results and Provide Corporate Update on Thursday, May 12, 2022

May 05, 2022

From Virios Therapeutics, Inc.

Via Business Wire

Earnings Scheduled For May 12, 2022 ↗

May 12, 2022

Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter.

Via Benzinga

Virios Therapeutics Completes Enrollment of 425 Patients in Phase 2b “FORTRESS” Clinical Trial for Fibromyalgia

April 28, 2022

From Virios Therapeutics, Inc. (VIRI)

Via Business Wire

Virios Therapeutics: Q4 Earnings Insights ↗

March 17, 2022

Virios Therapeutics (NASDAQ:VIRI) reported its Q4 earnings results on Thursday, March 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement....

Via Benzinga

Virios Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

March 17, 2022

From Virios Therapeutics, Inc.

Via Business Wire

Earnings Scheduled For March 17, 2022 ↗

March 17, 2022

Companies Reporting Before The Bell • TransGlobe Energy (NASDAQ:TGA) is estimated to report earnings for its fourth quarter. • Ikena Oncology (NASDAQ:IKNA) is...

Via Benzinga

A Preview Of Virios Therapeutics's Earnings ↗

March 16, 2022

Virios Therapeutics (NASDAQ:VIRI) is set to give its latest quarterly earnings report on Thursday, 2022-03-17. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

Virios Therapeutics Announces Research Collaboration Exploring the Potential of Combination Antiviral Therapy for Treating Long COVID

February 28, 2022

From Virios Therapeutics, Inc. (VIRI)

Via Business Wire

An Innovative Approach To Antiviral Therapies And Treating Fibromyalgia (FM) Disease? ↗

February 02, 2022

Photo by Fusion Medical Animation on Unsplash Greg Duncan, Chairman and CEO of Virios Therapeutics Inc. (NASDAQ: VIRI), was a guest speaker at Benzinga’s All Access on Jan. 28, 2022.

Via Benzinga

Benzinga Announces This Week's All Access Guests ↗

January 27, 2022

Benzinga is thrilled to announce the guest lineup for our next All Access show, presented by RedChip, set to air Friday, January 28 at 9:15 am ET. The Lineup 9:15 am:...

Via Benzinga

RedChip Partners with Benzinga to Host Exclusive Small-Cap CEO Interview Series on January 28

January 26, 2022

ORLANDO, FL / ACCESSWIRE / January 26, 2022 / RedChip Companies, Inc., an international investor relations, media, and research firm focused on microcap and small-cap companies, is pleased to announce...

From RedChip

Via AccessWire

Virios Therapeutics to Present at the Virtual H.C. Wainwright BioConnect Conference

January 04, 2022

From Virios Therapeutics, Inc. (VIRI)

Via Business Wire

Virios Therapeutics Achieves Over 50% Enrollment Milestone in its Phase 2b Clinical Trial for Fibromyalgia

December 01, 2021

From Virios Therapeutics, Inc. (VIRI)

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021 ↗

December 15, 2021

Upgrades B of A Securities upgraded the previous rating for ONE Gas Inc (NYSE:

Via Benzinga

Virios Therapeutics Announces Third Quarter 2021 Financial Results and Provides Corporate Update

November 11, 2021

From Virios Therapeutics, Inc. (VIRI)

Via Business Wire

Virios Therapeutics to Report Third Quarter 2021 Financial Results and Provide Corporate Update on Thursday, November 11, 2021

November 04, 2021

From Virios Therapeutics, Inc. (VIRI)

Via Business Wire

Virios Therapeutics Granted New Patent for Antiviral Inhibitor Combination

September 08, 2021

From Virios Therapeutics, Inc.

Via Business Wire

64 Biggest Movers From Yesterday ↗

November 02, 2021

Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares climbed 137.4% to close at $6.03 on Monday on abnormally-high volume. The stock is seeing increased interest by traders on...

Via Benzinga

Virios Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

September 02, 2021

From Virios Therapeutics, Inc. (VIRI)

Via Business Wire

Stocks That Hit 52-Week Lows On Friday ↗

August 20, 2021

On Friday morning, 155 companies achieved new lows for the year. Interesting Points: Marqeta (NASDAQ:MQ) was the largest firm on a market cap basis to set a new 52-...

Via Benzinga

Virios Therapeutics Announces New Social Media Profiles

August 19, 2021

From Virios Therapeutics, Inc.

Via Business Wire

Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021

August 16, 2021

LOS ANGELES, CA / ACCESSWIRE / August 16, 2021 / The SNN Network Summer Virtual Event will take place on August 17-19, 2021, where 60 SmallCap, MicroCap and NanoCap public and private companies will be...

From Stock News Now

Via AccessWire

Topics Cannabis

Virios Therapeutics CEO Highlights Novel Therapeutic Approach for Treating Fibromyalgia and Irritable Bowel Syndrome in Stock News Now Video Interview

August 16, 2021

From Virios Therapeutics, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.